Back to Rafferty Asset Management, LLC Rafferty Asset Management, LLC

AXSMAXSM

Showing 7 of 27 quarters

Position history for Rafferty Asset Management, LLCRafferty Asset Management, LLC's holdings in Axsome Therapeutics, Inc.

No. Rafferty Asset Management exited its AXSM (Axsome Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 1,567 shares worth $286,197. Rafferty Asset Management first reported AXSM in Q3 2019 and held it in 23 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$420,951

Total Shares Change

-4,684

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$169.02
0
2025-Q4
Decreased
1,567
-10.1%
$286,1970.0%$182.64
0
2025-Q3
Decreased
1,742
-20.8%
$211,5660.0%$121.45
0
2025-Q2
Decreased
2,199
-19.4%
$229,5540.0%$104.39
0
2025-Q1
Decreased
2,729
-24.8%
$318,2830.0%$116.63
0
2024-Q4
Decreased
3,630
-22.5%
$307,1340.0%$84.61
0
2024-Q3
Decreased
4,684
-14.5%
$420,9510.0%$89.87
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used